Coronary Disease - PCI

JANS Article

Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial

March 26, 2026 | Vincent SierGold Contributor

In this pre-specified analysis of the EXCEL trial, 1,882 patients with left main disease underwent percutaneous coronary intervention (PCI) (n=952) or coronary artery bypass grafting (CABG) (n=930). At five years, spontaneous myocardial infarction (MI) was...

JANS Article

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Unprotected Left Main Stenosis: 10-Year Final Results From the Randomised, Open-Label, Non-Inferiority NOBLE Trial

May 13, 2026 | Vincent SierGold Contributor

In this article, the authors report the 10-year final results of the NOBLE trial comparing percutaneous coronary intervention (PCI) with newer generation drug–eluting stents vs coronary artery bypass grafting (CABG)...

JANS Article

Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial

March 26, 2026 | Vincent SierGold Contributor

In this pre-specified analysis of the EXCEL trial, 1,882 patients with left main disease underwent percutaneous coronary intervention (PCI) (n=952) or coronary artery bypass grafting (CABG) (n=930). At five years,...

JANS Article

Percutaneous vs. Surgical Revascularization of Non-ST-Segment Elevation Myocardial Infarction With Multivessel Disease: The SWEDEHEART Registry

March 6, 2025 | Mateo Marin-CuartasGold Contributor

The debate continues over long-term outcomes of percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel disease. This study,...

JANS Article

Commentary: What Matters More—Method of Revascularization or Completeness?

April 24, 2024 | Mujtaba MubashirGold Contributor

This commentary succinctly reviews the 2021 coronary revascularization and the 2023 chronic coronary disease guidelines with relation to use of PCI and CABG in patients with ischemic cardiomyopathy and ejection...

JANS Article

Five-Year Outcomes After PCI or CABG for Left Main Coronary Disease

November 6, 2019 | Mark FergusonGold Contributor

In this randomized trial, percutaneous coronary intervention and CABG had equivalent outcomes for the composite of death, stroke, or myocardial infarction at five years for patients with left main disease...

JANS Article

Complete Revascularization with Multivessel PCI for Myocardial Infarction

October 19, 2019 | Aristotle ProtopapasGold ContributorGold Commentor

Quite interesting to see that the incidence of revascularisation after multivessel PCA (the additional element on the second co-primary outcome) appears to have occured in more than 1% of the...

JANS Article

Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease

October 18, 2019 | Mark FergusonGold Contributor

Using data from the FREEDOM (Future Revascularizaiton Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial, the authors developed an 8 variable model that predicts individual risk...

JANS Article

The Gender Gap in ACS: Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome

October 15, 2019 | Mark FergusonGold Contributor

Using gender specific thresholds for abnormalities in cardiac troponin I, the rate of injury among women increased by 42%. This did not translate into improved management of women, who remained...

JANS Article

CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial

September 14, 2019 | Edward SavageBronze Contributor

This study reports ten year outcomes of the STICH trial. Comparing CABG to medical therapy groups, the authors note that CABG reduced all cause, cardiovascular, and heart failure hospitalizations. This...

JANS Article

Most Promising’ Cardioprotective Strategy Ends Up a Bust

September 3, 2019 | Mark FergusonGold Contributor

Remote ischemic preconditioning did not influence 12-month survival or readmission rates in a randomized trial involving more than 5,400 patients undergoing percutaneous coronary intervention after ST-segment elevation MI.

...
JANS Article

A More COMPLETE Picture of Revascularization in STEMI

September 1, 2019 | Aristotle ProtopapasGold ContributorGold Commentor

Interesting viewpoint of a cardiologist on low-SYNTAX subjects.

...
JANS Article

Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients With Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials

August 29, 2019 | Aristotle ProtopapasGold ContributorGold Commentor

An interesting meta-analysis discouraging perhaps the use of this KATP modulator, especially after surgical revascularization where optimization of serum potassium is generally sought.

...
LOAD MORE
ADVERTISE ON CTSNET